Kim, Heeseong
Kim, Seung Woo
Choi, Cheoljun
Joo, SungUg
Kim, Gibae
Kim, Minjae
Yang, Eunsuk
Lee, Jangwon
Chung, Sukjae
Jeong, Lak Shin
Lee, Yun-Hee https://orcid.org/0000-0002-0542-4705
Funding for this research was provided by:
National Research foundation (NRF-2022R1A6A1A03046247)
National Research Foundation Korea (RS-2023-00213572, RS- 2024-00400118, RS-2025-16063709)
Seoul National University
Article History
Received: 12 May 2025
Accepted: 28 October 2025
First Online: 7 November 2025
Declarations
:
: Yun-Hee Lee is an Editor of Archives of Pharmacal Research and was not involved in the peer review or editorial decision-making for this article. Lak Shin Jeong is the Chief Executive Officer of Future Medicine, Inc., which provided the study compound and holds the associated patent. The remaining authors declare no competing interests.